Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges

Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Seegobin, Karan, Gharia, Bharatsinh, Maharaj, Satish, Zuberi, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109582/
https://www.ncbi.nlm.nih.gov/pubmed/30159181
http://dx.doi.org/10.1155/2018/2080185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109582/
https://www.ncbi.nlm.nih.gov/pubmed/30159181
http://dx.doi.org/10.1155/2018/2080185

Ejemplares similares